Last close As at 05/08/2026
GBP2.22
▲ 1.00 (0.45%)
Market capitalisation
GBP508m
Research: TMT
GB Group’s (GBG’s) H121 results were in line with its recent trading update, confirming revenue growth of 10% y-o-y and normalised EPS growth of 25% y-o-y. COVID-19-related cost reduction and cash preservation measures helped reduce net debt by £32m h-o-h. FY21 revenue guidance is unchanged and the company expects to return to more normal levels of investment (both opex and capex) in H221. We have made small upgrades to our forecasts.
GB Group |
Back to investing for growth |
H121 results |
Software & comp services |
8 December 2020 |
Share price performance
Business description
Next events
Analyst
GB Group is a research client of Edison Investment Research Limited |
||||||||||||||||||||||||||||||||||||||||||||||||
GB Group’s (GBG’s) H121 results were in line with its recent trading update, confirming revenue growth of 10% y-o-y and normalised EPS growth of 25% y-o-y. COVID-19-related cost reduction and cash preservation measures helped reduce net debt by £32m h-o-h. FY21 revenue guidance is unchanged and the company expects to return to more normal levels of investment (both opex and capex) in H221. We have made small upgrades to our forecasts.
Year end |
Revenue (£m) |
EBITA* |
PBT* |
Diluted EPS* |
DPS |
P/E |
03/19 |
143.5 |
32.0 |
31.3 |
15.4 |
3.0 |
58.5 |
03/20 |
199.1 |
47.9 |
45.7 |
17.9 |
0.0 |
50.3 |
03/21e |
199.2 |
44.3 |
42.7 |
16.5 |
6.0 |
54.7 |
03/22e |
215.0 |
47.5 |
46.4 |
17.8 |
3.3 |
50.6 |
03/23e |
237.4 |
53.0 |
52.1 |
19.8 |
3.6 |
45.4 |
Note: *EBITA, PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Strong cash generation in H121
GBG reported results in line with October’s trading update, with constant currency organic revenue growth of 10.4% y-o-y for H121. The company saw accelerated growth from some existing customers as they extended their use of digital services while customer contract renewal rates were in line with prior years. New contracts were more difficult to sign in some sectors and geographies, but GBG won new business against competitors. The strong growth in revenue translated to a 24.5% increase in adjusted operating profit and a 25.2% increase in normalised diluted EPS. Net debt reduced by £32m over H121 to close the period at £2.5m. The company confirmed it will pay an interim dividend of 3.0p per share.
Outlook maintained; investment reinstated
While there are still uncertainties in the outlook due to ongoing COVID-19 restrictions, GBG is maintaining its FY21 guidance for marginal growth in revenue. The acceleration in digital transformation during the pandemic highlights the long-term structural growth opportunity for GBG. Having conserved cash and maintained profitability during H1, the company is ready to resume investment in priority areas and has an active acquisition pipeline. Reflecting H121 results we have made small upgrades to our forecasts: FY21 normalised diluted EPS +1.1%, FY22 +2.7% and FY23 +4.0%.
Valuation: Premium rating reflects growth potential
GBG trades at a premium to the UK software and IT services sectors and at the upper end of its ID management peer group on a P/E basis, reflecting its strong growth outlook (post COVID-19), high recurring revenues and strong balance sheet. Our reverse DCF analysis estimates the current share price is factoring in operating margins of 25.8% and revenue growth of c 16% per year from FY24, at the upper end of the group’s revenue and margin targets. Outside of faster than expected COVID-19 recovery, triggers for upside could include successful cross-selling from recent acquisitions, adoption of GBG’s combined identity/location solution and in the medium term, accretive acquisitions.
Review of H121 results
Exhibit 1: H121 results highlights
£m |
H121 |
H120 |
y-o-y |
Revenues |
103.5 |
94.3 |
9.8% |
Gross profit |
72.6 |
68.3 |
6.4% |
Gross margin |
70.2% |
72.4% |
-2.2% |
Adjusted operating profit |
26.8 |
21.6 |
24.5% |
Adjusted operating margin |
25.9% |
22.8% |
3.1% |
Reported operating profit |
15.7 |
9.7 |
61.7% |
Reported operating margin |
15.1% |
10.3% |
4.9% |
Normalised diluted EPS (p) |
10.0 |
8.0 |
25.2% |
Adjusted basic EPS (p)** |
11.8 |
9.0 |
30.5% |
Reported basic EPS (p) |
6.1 |
2.9 |
110.3% |
Net debt* |
2.5 |
53.8 |
-95.4% |
Source: GB Group. Note: EBITA = operating profit before exceptional items, amortisation of acquired intangibles and share-based payments. *Net of capitalised financing costs. **Company adjusted measure uses reported tax charge.
H121 results were substantially in line with the October trading update. H121 revenue was 9.8% higher year-on-year, or 10.4% higher on a constant currency basis. Exhibits 2 and 3 show the split of revenue by sector and by geography. Around 14% of revenue was generated from COVID-19 challenged sectors, down from 18% in FY20. The US saw substantial growth in revenue (73% yoy, benefiting from a one-off contract in Identity), while the UK declined 16% y-o-y, reflecting the UK exposure to more challenged sectors such as gaming, travel and leisure.
|
Exhibit 2: H121 revenue split by sector |
Exhibit 3: Revenue split by geography |
|
|
|
Source: GB Group |
Source: GB Group |
|
Exhibit 2: H121 revenue split by sector |
|
|
Source: GB Group |
|
Exhibit 3: Revenue split by geography |
|
|
Source: GB Group |
The company took action at the beginning of the COVID-19 pandemic to reduce costs to preserve cash. Combined with the benefit of a one-off contract in the US Identity business, this resulted in strong growth in profitability. Adjusted operating profit was 24.5% higher year-on-year, which resulted in a 3.1pp margin increase. Net finance costs reduced from £1.2m in H120 to £0.8m in H121 reflecting the reduction in debt over the period. The reported tax rate was 20.8% in H121 compared to 34.0% in H120 (when profit was weighted towards higher rate countries).
Net debt reduced from £34.6m at the end of FY20 to £2.5m at the end of H121 through higher operating cash flow and a reduction in capex as well as no final dividend for FY20. Adjusted EBITDA cash conversion of 155% in H121 compares to 103% in H120. The company paid down £27.5m of its revolving credit facility during H1 and since the end of H1 has repaid a further £15m.
The company acquired an 11% stake in a Singapore-based business called CredoLab for £2.3m via the issue of 322k shares.
As previously announced, the company will pay a 3.0p interim dividend. GBG does not usually pay an interim dividend – this is in effect to compensate for not paying a final dividend for FY20 – and we expect a final dividend to be announced for FY21 before reverting to paying one dividend a year.
Divisional performance
Exhibits 4 and 5 summarise performance by division. The contractual arrangements for each service differ, with the vast majority of fraud revenues coming from licences, whereas the majority of Identity revenues come from volume-based contracts.
Exhibit 4: Divisional performance
£m |
H121 |
H120 |
y-o-y |
Revenues |
|||
Fraud |
12.28 |
16.82 |
(27.0%) |
Identity |
64.53 |
51.19 |
26.1% |
Location |
25.20 |
23.26 |
8.4% |
Unallocated (Engage) |
1.53 |
3.07 |
(50.0%) |
Total revenues |
103.55 |
94.34 |
9.8% |
Adjusted operating profit (AOP) |
|||
Fraud |
2.22 |
5.40 |
(58.9%) |
Identity |
23.32 |
15.78 |
47.8% |
Location |
7.78 |
6.63 |
17.4% |
Unallocated (Engage) |
(6.49) |
(6.26) |
3.7% |
Total AOP |
26.84 |
21.56 |
24.5% |
Adjusted operating margin |
|||
Fraud |
18.1% |
32.1% |
(14.0%) |
Identity |
36.1% |
30.8% |
5.3% |
Location |
30.9% |
28.5% |
2.4% |
Unallocated (Engage) |
-422.9% |
-203.9% |
(219.0%) |
Total adjusted operating margin |
25.9% |
22.8% |
3.1% |
Source: GB Group
Exhibit 5: Revenue by type per division
Group |
FY19 |
FY20 |
H121 |
Licence |
52% |
36% |
28% |
Transaction |
39% |
56% |
67% |
Services |
9% |
8% |
5% |
Fraud |
|||
Licence |
95% |
95% |
92% |
Transaction |
0% |
0% |
0% |
Services |
5% |
5% |
8% |
Identity |
|||
Licence |
21% |
7% |
5% |
Transaction |
78% |
91% |
94% |
Services |
1% |
3% |
1% |
Location |
|||
Licence |
76% |
60% |
56% |
Transaction |
23% |
32% |
35% |
Services |
1% |
8% |
9% |
Unallocated |
|||
Licence |
0% |
0% |
0% |
Transaction |
0% |
0% |
0% |
Services |
100% |
100% |
100% |
Source: GB Group
Identity – benefit from one-off contract in the US
The Identity business saw revenue growth of 26.1% y-o-y (27% constant currency), as one of its customers in the US provided identity verification services for a one-off project that is not expected to continue into H221. Transaction-based revenues increased to 94% of total divisional revenues, up from 91% in FY20 and 78% in FY19. This means that GBG is more directly exposed to the levels of activity seen by customers, so in some cases revenue will have declined as certain sectors eg travel and leisure were in lockdown, whereas other areas that benefited from increased customer activity such as the one-off contract referred to above contributed directly to revenue growth. The strong revenue growth translated to a 47.8% increase in adjusted operating profit and margin expansion from 30.8% in H120 to 36.1% in H121.
Location – boosted by shift to online retail
Location revenue increased 8.4% y-o-y (9% constant currency) helped by the accelerated shift to online commerce. The division saw growth across all regions. This dropped through to a 17.4% increase in adjusted operating profit and margin expansion from 28.5% in H120 to 30.9% in H121.
Fraud – tough comparison and harder to sign new business
GBG reported several multi-year licences in H120, creating a tough comparison for H121. In addition, there were fewer new contracts in the market as potential customers were focused on business continuity, and it was more difficult to undertake installation projects. This resulted in a 27.0% y-o-y revenue decline for the division (-26% constant currency), a 58.9% decline in adjusted operating profit and a reduction in the margin from 32.1% to 18.1%.
Unallocated – H120 restatement
In H121, the company decided to report the Datacare business within the Location division rather than as unallocated revenue and restated historical data accordingly. This removed £1.0m from H120 unallocated revenue and £0.1m from H120 adjusted operating profit. The remaining business generated revenue of £1.5m, down 50% y-o-y. Central costs of £6.0m were included within this division in H121 compared to £5.6m in H120. As the total unallocated adjusted operating loss increased only £0.2m y-o-y, this implies the remaining Engage business that is included here also managed to reduce its cost base.
Business update
During the course of H121, the group continued to invest in strategic projects:
■
Investment in CredoLab – GBG was already partnered with them. The business uses AI to help institutions make lending decisions without depending on traditional credit bureau data. This should enhance the capabilities of the Fraud business and allow GBG to serve new fintech and neobank market segments.
■
Extended machine learning capabilities across Fraud’s solutions. This enables greater accuracy in determining fraud probability and should improve fraud detection for customers.
■
Integrated global identity verification solutions to increase international reach for customers. IDology customers now have access to more data outside of the US, and customers in Australia and New Zealand now have better access to document and biometric capabilities.
■
Added new datasets in Argentina and Brazil as well as UK mobile.
■
Selectively added new hires and skills across the business.
Outlook and changes to forecasts
GBG reiterated guidance for FY21, expecting revenue to be marginally ahead of FY20 on an underlying basis. As there is not likely to be a repeat of the one-off project in Identity in H2, this implies revenues drop from £103.5m in H121 to more like £95.6m (-8.7% y-o-y). At the same time, the company is planning to deepen investment in initiatives required for future growth by reinvesting H221 operational leverage. Consequently, we do not expect a repeat of the 25% operating margin achieved in H1. We have revised our forecasts to reflect H121 results, with a small upgrade to FY21 normalised EPS (+1.1%) due to lower financing costs. For FY22 and FY23, we upgrade revenue and operating profit as increases in our Identity and Location forecasts outweigh lower Fraud forecasts. This results in normalised EPS forecasts 2.7% higher in FY22 and 4.0% higher in FY23. We forecast a shift to a net cash position in FY22. The company continues to consider M&A and currently has c £105m additional borrowing capacity (£75m available immediately and a £30m accordion facility).
Exhibit 6: Changes to forecasts
£m |
FY21e |
FY21e |
|
|
FY22e |
FY22e |
|
|
FY23e |
FY23e |
|
|
old |
new |
change |
y-o-y |
old |
new |
change |
y-o-y |
old |
new |
change |
y-o-y |
|
Revenues |
199.2 |
199.2 |
0.0% |
0.0% |
213.2 |
215.0 |
0.8% |
7.9% |
234.7 |
237.4 |
1.1% |
10.4% |
Gross profit |
144.8 |
143.4 |
(1.0%) |
(0.5%) |
153.5 |
154.8 |
0.8% |
7.9% |
169.0 |
170.9 |
1.1% |
10.4% |
Gross margin |
72.7% |
72.0% |
(0.7%) |
(0.4%) |
72.0% |
72.0% |
0.0% |
0.0% |
72.0% |
72.0% |
0.0% |
0.0% |
EBITDA |
48.4 |
48.3 |
(0.1%) |
(6.6%) |
51.1 |
51.7 |
1.1% |
7.0% |
56.1 |
57.3 |
2.2% |
10.9% |
EBITDA margin |
24.3% |
24.3% |
(0.0%) |
(1.7%) |
24.0% |
24.1% |
0.1% |
(0.2%) |
23.9% |
24.2% |
0.2% |
0.1% |
EBITA |
44.4 |
44.3 |
(0.1%) |
(7.5%) |
46.9 |
47.5 |
1.3% |
7.2% |
51.7 |
53.0 |
2.4% |
11.4% |
EBITA margin |
22.3% |
22.3% |
(0.0%) |
(1.8%) |
22.0% |
22.1% |
0.1% |
(0.1%) |
22.0% |
22.3% |
0.3% |
0.2% |
PBT |
42.2 |
42.7 |
1.1% |
(6.6%) |
45.2 |
46.4 |
2.7% |
8.8% |
50.1 |
52.1 |
4.0% |
12.2% |
EPS - normalised, diluted (p) |
16.3 |
16.5 |
1.1% |
(8.0%) |
17.3 |
17.8 |
2.7% |
8.1% |
19.1 |
19.8 |
4.0% |
11.5% |
EPS - reported (p) |
7.1 |
7.3 |
2.0% |
(17.3%) |
8.1 |
8.5 |
5.9% |
17.1% |
10.1 |
10.8 |
7.7% |
27.0% |
DPS (p) |
6.0 |
6.0 |
0.0% |
N/A |
3.3 |
3.3 |
0.0% |
(45.0%) |
3.6 |
3.6 |
0.0% |
9.1% |
Net debt/(cash) |
12.0 |
15.5 |
28.6% |
(55.3%) |
(16.6) |
(14.0) |
(15.6%) |
(191%) |
(48.6) |
(47.3) |
(2.6%) |
237% |
Divisional forecasts |
||||||||||||
Revenue |
||||||||||||
Identity |
113.3 |
115.8 |
2.2% |
9.8% |
122.3 |
125.8 |
2.9% |
8.7% |
135.5 |
139.4 |
2.9% |
10.8% |
Location |
45.8 |
50.2 |
9.6% |
-2.5% |
49.5 |
54.2 |
9.6% |
8.0% |
55.4 |
60.7 |
9.6% |
12.0% |
Fraud |
33.8 |
30.1 |
(10.8%) |
-15.1% |
36.5 |
32.5 |
(11.0%) |
7.7% |
39.8 |
35.3 |
(11.3%) |
8.8% |
Group |
199.2 |
199.2 |
0.0% |
0.0% |
213.2 |
215.0 |
0.8% |
7.9% |
234.7 |
237.4 |
1.1% |
10.4% |
Adjusted operating profit |
||||||||||||
Identity |
35.9 |
37.2 |
3.6% |
10.5% |
37.0 |
38.1 |
2.9% |
2.6% |
41.0 |
42.2 |
2.9% |
10.8% |
Location |
11.2 |
14.3 |
27.5% |
-4.5% |
13.9 |
15.2 |
9.6% |
6.3% |
15.5 |
17.0 |
9.6% |
12.0% |
Fraud |
8.9 |
6.9 |
(23.2%) |
-48.9% |
10.2 |
9.1 |
(11.0%) |
32.3% |
11.1 |
9.9 |
(11.3%) |
8.8% |
Group |
44.4 |
44.3 |
(0.1%) |
-7.5% |
46.9 |
47.5 |
1.3% |
7.2% |
51.7 |
53.0 |
2.4% |
11.4% |
Adjusted operating margin |
||||||||||||
Identity |
31.7% |
32.1% |
30.3% |
30.3% |
30.3% |
30.3% |
||||||
Location |
24.5% |
28.4% |
28.0% |
28.0% |
28.0% |
28.0% |
||||||
Fraud |
26.5% |
22.8% |
28.0% |
28.0% |
28.0% |
28.0% |
||||||
Group |
22.3% |
22.3% |
22.0% |
22.1% |
22.0% |
22.3% |
Source: Edison Investment Research
Valuation
GBG trades at a premium to the UK software and IT services sectors and at the upper end of its ID management peer group on a P/E basis, reflecting its growth prospects (after COVID-19 disruption recedes) and high recurring revenues. The company also has a solid balance sheet and is cash generative, positioning it well to weather this period of uncertainty.
Our reverse DCF analysis, which uses a WACC of 7.5%, long-term growth of 3% and our forecasts to FY23, estimates the current share price is factoring in operating margins of 25.8% and revenue growth of c 16% per year from FY24, at the upper end of the group’s revenue and margin targets. Triggers for upside from the current level, apart from faster than expected recovery as COVID-19 restrictions are reduced, could include accretive acquisitions, successful cross-selling from recent acquisitions and adoption of GBG’s combined identity/location solution.
Exhibit 7: Valuation metrics
Rev growth (%) |
EBIT margin (%) |
EV/sales (x) |
EV/EBIT (x) |
P/E |
Div yield (%) |
|||||||
CY |
NY |
CY |
NY |
CY |
NY |
CY |
NY |
CY |
NY |
CY |
NY |
|
GBG |
0.0 |
7.9 |
22.3 |
22.1 |
9.0 |
8.3 |
40.4 |
37.7 |
54.7 |
50.6 |
0.7 |
0.4 |
Ave ID Management |
4.9 |
7.7 |
28.2 |
28.9 |
6.4 |
6.4 |
24.3 |
22.0 |
31.8 |
27.0 |
0.9 |
1.1 |
Median ID Management |
3.7 |
7.3 |
28.3 |
28.8 |
5.8 |
6.1 |
25.5 |
23.1 |
31.7 |
27.3 |
0.6 |
1.0 |
Ave UK Software |
13.9 |
13.6 |
-2.4 |
6.3 |
5.5 |
4.8 |
14.4 |
16.7 |
19.9 |
22.6 |
0.9 |
1.1 |
Median UK Software |
7.1 |
7.8 |
12.4 |
14.1 |
3.7 |
3.4 |
20.8 |
19.5 |
25.2 |
24.4 |
0.1 |
0.4 |
Ave UK IT Services |
10.3 |
11.7 |
10.7 |
13.0 |
3.3 |
3.1 |
51.1 |
19.8 |
32.2 |
37.3 |
1.1 |
1.3 |
Median UK IT Services |
4.2 |
9.8 |
12.9 |
13.6 |
3.4 |
3.0 |
27.6 |
21.7 |
34.0 |
28.8 |
0.5 |
1.1 |
Source: Edison Investment Research, Refinitiv (as at 7 December 2020)
Exhibit 8: Financial summary
£'000s |
2017 |
2018 |
2019 |
2020 |
2021e |
2022e |
2023e |
||
Year end 31 March |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
PROFIT & LOSS |
|||||||||
Revenue |
|
|
87,468 |
119,702 |
143,504 |
199,101 |
199,184 |
214,957 |
237,385 |
Cost of Sales |
(20,302) |
(27,092) |
(36,060) |
(54,914) |
(55,771) |
(60,188) |
(66,468) |
||
Gross Profit |
67,166 |
92,610 |
107,444 |
144,187 |
143,412 |
154,769 |
170,917 |
||
EBITDA |
|
|
18,734 |
28,741 |
34,080 |
51,739 |
48,318 |
51,704 |
57,337 |
Operating Profit (before amort. and except.) |
17,006 |
26,311 |
32,031 |
47,945 |
44,350 |
47,549 |
52,987 |
||
Acquired intangible amortisation |
(4,022) |
(7,885) |
(10,316) |
(19,008) |
(18,900) |
(18,900) |
(17,900) |
||
Exceptionals |
(1,410) |
(2,143) |
(4,003) |
(1,552) |
(93) |
0 |
0 |
||
Share of associate |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||
Share based payments |
(994) |
(2,375) |
(2,287) |
(4,541) |
(4,995) |
(5,495) |
(6,044) |
||
Operating Profit |
10,580 |
13,908 |
15,425 |
22,844 |
20,362 |
23,155 |
29,043 |
||
Net Interest |
(498) |
(508) |
(689) |
(2,218) |
(1,655) |
(1,105) |
(855) |
||
Profit Before Tax (norm) |
|
|
16,508 |
25,803 |
31,342 |
45,727 |
42,695 |
46,444 |
52,132 |
Profit Before Tax (FRS 3) |
|
|
10,082 |
13,400 |
14,736 |
20,626 |
18,707 |
22,050 |
28,188 |
Tax |
668 |
(2,746) |
(2,583) |
(3,562) |
(4,490) |
(5,292) |
(6,765) |
||
Profit After Tax (norm) |
13,206 |
20,642 |
24,760 |
35,210 |
32,448 |
35,298 |
39,621 |
||
Profit After Tax (FRS 3) |
10,750 |
10,654 |
12,153 |
17,064 |
14,217 |
16,758 |
21,423 |
||
Ave. Number of Shares Outstanding (m) |
131.6 |
150.6 |
158.1 |
193.6 |
195.1 |
196.4 |
197.7 |
||
EPS - normalised (p) |
|
|
10.0 |
13.7 |
15.7 |
18.2 |
16.6 |
18.0 |
20.0 |
EPS - normalised and fully diluted (p) |
|
9.9 |
13.5 |
15.4 |
17.9 |
16.5 |
17.8 |
19.8 |
|
EPS - (IFRS) (p) |
|
|
8.2 |
7.1 |
7.7 |
8.8 |
7.3 |
8.5 |
10.8 |
Dividend per share (p) |
2.4 |
2.7 |
3.0 |
0.0 |
6.0 |
3.3 |
3.6 |
||
Gross Margin (%) |
76.8 |
77.4 |
74.9 |
72.4 |
72.0 |
72.0 |
72.0 |
||
EBITDA Margin (%) |
21.4 |
24.0 |
23.7 |
26.0 |
24.3 |
24.1 |
24.2 |
||
Operating Margin (before GW and except.) (%) |
19.4 |
22.0 |
22.3 |
24.1 |
22.3 |
22.1 |
22.3 |
||
BALANCE SHEET |
|||||||||
Fixed Assets |
|
|
105,653 |
170,284 |
438,683 |
430,219 |
407,061 |
389,006 |
371,857 |
Intangible Assets |
98,753 |
161,372 |
425,646 |
414,505 |
387,040 |
367,990 |
349,940 |
||
Tangible Assets |
2,856 |
4,700 |
4,815 |
9,420 |
10,502 |
11,497 |
12,398 |
||
Other fixed assets |
4,044 |
4,212 |
8,222 |
6,294 |
9,519 |
9,519 |
9,519 |
||
Current Assets |
|
|
48,914 |
61,121 |
76,522 |
95,984 |
81,538 |
112,922 |
150,268 |
Debtors |
30,569 |
37,969 |
54,992 |
66,554 |
71,706 |
77,385 |
85,459 |
||
Cash |
17,618 |
22,753 |
21,189 |
27,499 |
4,332 |
30,039 |
59,311 |
||
Other |
727 |
399 |
341 |
1,931 |
5,499 |
5,499 |
5,499 |
||
Current Liabilities |
|
|
(44,444) |
(56,942) |
(77,030) |
(86,459) |
(86,892) |
(93,520) |
(102,505) |
Creditors |
(36,436) |
(56,100) |
(70,302) |
(80,280) |
(82,689) |
(89,317) |
(98,302) |
||
Contingent consideration |
(7,122) |
(45) |
(5,287) |
(6,179) |
(4,203) |
(4,203) |
(4,203) |
||
Short term borrowings |
(886) |
(797) |
(1,441) |
0 |
0 |
0 |
0 |
||
Long Term Liabilities |
|
|
(15,940) |
(16,711) |
(116,707) |
(94,810) |
(46,413) |
(36,727) |
(26,981) |
Long term borrowings |
(11,499) |
(8,451) |
(85,447) |
(62,139) |
(19,833) |
(16,002) |
(12,002) |
||
Contingent consideration |
0 |
0 |
0 |
0 |
(458) |
(458) |
(458) |
||
Other long term liabilities |
(4,441) |
(8,260) |
(31,260) |
(32,671) |
(26,122) |
(20,267) |
(14,521) |
||
Net Assets |
|
|
94,183 |
157,752 |
321,468 |
344,934 |
355,293 |
371,682 |
392,640 |
CASH FLOW |
|||||||||
Operating Cash Flow |
|
|
16,305 |
31,620 |
27,779 |
48,498 |
42,600 |
52,653 |
58,248 |
Net Interest |
(498) |
(545) |
(689) |
(1,768) |
(1,454) |
(936) |
(855) |
||
Tax |
(2,193) |
(3,247) |
(2,930) |
(6,386) |
(10,247) |
(11,147) |
(12,512) |
||
Capex |
(2,227) |
(2,018) |
(1,625) |
(1,339) |
(2,900) |
(3,000) |
(3,100) |
||
Acquisitions/disposals |
(36,840) |
(70,363) |
(255,101) |
(81) |
(2,089) |
0 |
0 |
||
Financing |
24,755 |
56,668 |
157,339 |
(1,553) |
(1,037) |
(2,000) |
(2,000) |
||
Dividends |
(2,775) |
(3,582) |
(4,049) |
(5,761) |
(5,855) |
(5,864) |
(6,509) |
||
Net Cash Flow |
(3,473) |
8,533 |
(79,276) |
31,610 |
19,018 |
29,706 |
33,272 |
||
Opening net debt/(cash) |
|
|
(8,673) |
(5,233) |
(13,505) |
65,699 |
34,640 |
15,501 |
(14,037) |
HP finance leases initiated |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||
Other |
33 |
(261) |
72 |
(551) |
121 |
(169) |
0 |
||
Closing net debt/(cash) |
|
|
(5,233) |
(13,505) |
65,699 |
34,640 |
15,501 |
(14,037) |
(47,309) |
Source: GB Group, Edison Investment Research
|
|
Research: Metals & Mining
On 7 December, Lepidico announced that it had established a strategic collaboration with the UK’s Cornish Lithium (CLL, a private company) according to which it has granted CLL an exclusive licence over its L-Max and LOH-Max technologies (plus 100m options) for C$4.0m. Proceeds of the deal have allowed Lepidico to retire all of its convertible bond debt (see page six of our 5 November note Enter the US government), protecting shareholders from unnecessary convertible dilution, as well as confirming a parallel path by which to commercialise its technology. The news comes less than a fortnight after Galaxy announced that it had ceased to be a substantial shareholder in Lepidico (indicating an ever-waning overhang of stock in the market) and leaves Lepidico as the obvious choice for investors looking to gain exposure to CLL in public markets. Lepidico’s shares advanced 12.5% on the news in Australia.